Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Announces NDA Acceptance Of Repotrectinib By China's NMPA

June 28 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB ANNOUNCES NDA ACCEPTANCE OF REPOTRECTINIB FOR
PATIENTS
WITH ROS1-POSITIVE NSCLC BY CHINA’S NMPA

Source text for Eikon:  ID:nGNX6TSqfm 
Further company coverage:  9688.HK 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news